期刊
AMERICAN JOURNAL OF MEDICAL GENETICS PART A
卷 167, 期 7, 页码 1659-1667出版社
WILEY
DOI: 10.1002/ajmg.a.37070
关键词
Aboriginal; indigenous; mTOR; megalencephaly; rapamycin; repurposing; RASopathy
资金
- Raine Clinician Research Fellowship
- RD-Connect
- Neuromics
We report on three Aboriginal Australian siblings with a unique phenotype which overlaps with known megalencephaly syndromes and RASopathies, including Costello syndrome. A gain-of-function mutation in MTOR was identified and represents the first reported human condition due to a germline, familial MTOR mutation. We describe the findings in this family to highlight that (i) the path to determination of pathogenicity was confounded by the lack of genomic reference data for Australian Aboriginals and that (ii) the disease biology, functional analyses in this family, and studies on the tuberous sclerosis complex support consideration of an mTOR inhibitor as a therapeutic agent. (C) 2015 Wiley Periodicals, Inc.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据